Hungaropharma Zrt. acquired the 100% shareholding in Infomix Kft in November 2019.

Founded in 1990, Infomix Kft. provides self-developed medical software for doctors, children’s visitor nurses, nurses and assistants employed in basic and specialised healthcare. The software of the company  are customisable, patient documentation applications are compatible with the Electronic Healthcare Service Provision Space that help healthcare professionals in performing administrative tasks more easily and quickly. Today, every second GP practice uses Infomix software.

Hungaropharma Zrt. is the largest player in the Hungarian pharmaceutical wholesale market with its 40% market share. It sells nearly 135 million boxes of medicines annually, with over 2,400 pharmacies and 150 hospitals as clients.

With the acquisition of Infomix Kft., Hungaropharma Zrt. joined the drug supply value chain on a new thread, without affecting pharmacies, with the aim of expanding its services and further developing Infomix Kft as a capital-intensive professional investor.

During the acquisition process, the exclusive transaction advisor of Hungaropharma Zrt. was Concorde MB Partners.

By publishing the independent expert opinion on 6 November 2019, Concorde MB Partners completed its duties in supporting the Board of Directors of ELMŰ and ÉMÁSZ in connection with the public offer of the shares of the two companies launched by E.On.

In October 2019, as part of the acquisition of Innogy, a German energy company, E.On Hungária launched a public call for tender for the owners of ELMŰ and ÉMÁSZ. It is a legal obligation for Board of Directors of the targeted companies to hire a financial advisor to produce an independent expert opinion during the public offer process. The joint Board of Directors of ELMŰ and ÉMÁSZ commissioned the experts of Concorde MB Partners. Through this collaboration, CMBP’s experts not only evaluated the shares of the companies, but supported their entire transaction process, drawing on their capital market experience.

The exclusive transaction advisor of the Board of Directors of ELMŰ and ÉMÁSZ was Concorde MB Partners.

In October 2019, the sale of Terracotta Magyarország Kft. and its subsidiary, Terra-Tőzeg Tőzegfeldolgozó Kft was successfully completed. Terracotta Magyarország Kft is the leading domestic wholesaler of hobby horticultural products (flowerpots, potting soils, grass seeds, liquid fertilizers, and garden accessories), while Terra-Tőzeg Tőzegfeldolgozó Kft is engaged in peat processing and potting soil production.

Terracotta Magyarország Kft., which was founded 23 years ago, is a leading distributor of gardening tools. With more than 1,500 SKUs, it serves almost all major hypermarkets, DIY stores and discount stores, providing over 1,000 points of sale in Hungary and the CEE region.

Terra-Tőzeg Tőzegfeldolgozó Kft. produces a variety of potting soil and liquid fertilizers for horticultural purposes, of which approximately 75% is sold through Terracotta in Hungary.

In addition to its own products, the Company also produces branded products for chain stores.

The Group was acquired by four private individuals (led by an investment manager) who wants to capitalize on their expertise in various areas of the economy.

This deal is a further example of a transaction, where the buyer was an external management team (MBI – Management Buy-In) in Hungary.

The exclusive transaction advisor of  Terracotta Magyarország during the acquisition process was Concorde MB Partners.